At the meeting of 5 May 2021 the RMA:
Determined Statements of Principles (SOPs) for:
|gastro-oesophageal reflux disease||61/2021||62/2021|
|malignant neoplasm of the oral cavity, oropharynx and hypopharynx||65/2021||66/2021|
|porphyria cutanea tarda||69/2021||70/2021|
Note: The investigation concerning 'mesangial IgA glomerulonephritis' has resulted in the determination of Statements of Principles concerning IgA nephropathy.
Determined New Statements of Principles (SOPs) for:
Determined Amendment Statements of Principles (SOPs) for:
The above SOPs take effect from 21 June 2021.
The above determinations conclude the previously advertised investigations into:
Decided to advertise the following investigations:
The above investigation notices appear in the Government Notices Gazette of 1 June 2021.